ERCC1 polymorphisms in patients with advanced bladder cancer treated with platinum-based chemotherapy

被引：0
|
作者：
Bamias, A.
Nikitas, N.
Karadimou, A.
Gika, D.
Karavasilis, V.
Briasoulis, E. C.
Chrisofos, M.
Murray, S.
Pectasides, D. G.
Dimopoulos, M. A.
机构：
[1] Alexandra Peripheral Gen Hosp, Athens, Greece
[2] Univ Athens, Athens, Greece
[3] Univ Thessaloniki, GR-54006 Thessaloniki, Greece
[4] Hellen Cooperat Oncol Grp Data Off, Athens, Greece
[5] Metropolitan Hosp, Athens, Greece
[6] Univ Athens, Sch Med, Dept Therapeut, GR-11527 Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e15066
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15066
引用
收藏
页数：1
相关论文
共 50 条
  • [11] The prognostic value of ERCC1 expression in gastric cancer patients treated with platinum-based chemotherapy: a meta-analysis
    Wei, Kong-Kong
    Jiang, Lei
    Wei, Yao-Yao
    Wang, Yu-Feng
    Qian, Xuan-Kun
    Dai, Qiang
    Guan, Quan-Lin
    TUMOR BIOLOGY, 2014, 35 (09) : 8721 - 8731
  • [12] Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy
    Sodja, Eva
    Knez, Lea
    Kern, Izidor
    Ovcaricek, Tanja
    Sadikov, Aleksander
    Cufer, Tanja
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (18) : 3378 - 3385
  • [13] ERCC1 Expression as a Predictor of Resistance to Platinum-based Chemotherapy in Primary Ovarian Cancer
    Muallem, Mustafa Zelal
    Braicu, Ioana
    Nassir, Mani
    Richter, Rolf
    Sehouli, Jalid
    Arsenic, Ruza
    ANTICANCER RESEARCH, 2014, 34 (1A) : 393 - 399
  • [14] ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas
    Laufs, Valeria
    Altieri, Barbara
    Sbiera, Silviu
    Kircher, Stefan
    Steinhauer, Sonja
    Beuschlein, Felix
    Quinkler, Marcus
    Willenberg, Holger S.
    Rosenwald, Andreas
    Fassnacht, Martin
    Ronchi, Cristina L.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 178 (02) : 181 - 188
  • [15] Association Between Polymorphisms of ERCC1 and XPD and Clinical Response to Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer
    Li, Fan
    Sun, Xinchen
    Sun, Ning
    Qin, Shukui
    Cheng, Hongyan
    Feng, Jifeng
    Chen, Baoan
    Cheng, Lu
    Lu, Zuhong
    Ji, Jiazhong
    Zhou, Yingfeng
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (05): : 489 - 494
  • [16] Association between ERCC1 polymorphisms and nephrotoxicity in non-small cell lung cancer patients undergoing platinum-based chemotherapy
    de Jong, Corine
    Deneer, Vera Henriette
    Kelder, Johannes
    Hunting, Cornelis Bernardus
    Herder, Gerarda
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [17] Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1
    Hamilton, Gerhard
    Rath, Barbara
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (01) : 17 - 24
  • [18] ERCC1 expression levels predict the outcome of platinum-based chemotherapies in advanced bladder cancer: a meta-analysis
    Li, Shan
    Wu, Junrong
    Chen, Yongbin
    Tang, Weizhong
    Peng, Qiliu
    Deng, Yan
    Xie, Li
    Wang, Jian
    Huang, Shan
    Li, Ruolin
    Qin, Xue
    Zhao, Jinmin
    ANTI-CANCER DRUGS, 2014, 25 (01) : 106 - 114
  • [19] Study of the Relationship between ERCC1 Polymorphisms and Response to Platinum-based Chemotherapy in Iranian Patients with Colorectal and Gastric Cancers
    Abyarghamsari, Mandiye
    Shirazi, Farshad Hosseini
    Tavakoli-Ardakani, Maria
    Rezvani, Hamid
    Mirzaei, Hamid Reza
    Salamzadeh, Jamshid
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (04): : 2163 - 2171
  • [20] ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy
    Kalikaki, Aristea
    Voutsina, Alexandra
    Koutsopoulos, Anastasios
    Papadaki, Chara
    Sfakianaki, Maria
    Yachnakis, Emmanouel
    Xyrafas, Alexandros
    Kotsakis, Athanasios
    Agelaki, Sofia
    Souglakos, John
    Mavroudis, Dimitrios
    Georgoulias, Vassilis
    CANCER INVESTIGATION, 2015, 33 (04) : 107 - 113
12345